Zimmer Biomet (ZBH) Stock Forecast & Price Target

$120.41
-0.37 (-0.31%)
(As of 10:40 AM ET)

Zimmer Biomet Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 15 Analyst Ratings

Analysts' Consensus Price Target

$139.39
15.76% Upside
High Forecast$172.00
Average Forecast$139.39
Low Forecast$120.00
TypeCurrent Forecast
4/24/23 to 4/23/24
1 Month Ago
3/25/23 to 3/24/24
3 Months Ago
1/24/23 to 1/24/24
1 Year Ago
4/24/22 to 4/24/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$139.39$137.84$137.60$134.19
Predicted Upside15.76% Upside12.32% Upside12.93% Upside7.74% Upside
Get Zimmer Biomet Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.

ZBH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ZBH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Zimmer Biomet Stock vs. The Competition

TypeZimmer BiometMedical CompaniesS&P 500
Consensus Rating Score
2.27
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside15.41% Upside1,011.19% Upside11.07% Upside
News Sentiment RatingVery Positive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/4/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$125.00 ➝ $130.00+0.36%
4/3/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$134.00 ➝ $140.00+8.12%
2/23/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Hold$130.00+0.61%
2/12/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$120.00 ➝ $130.00+3.83%
2/9/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$133.00 ➝ $135.00+9.93%
2/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$115.00 ➝ $125.00+1.90%
2/9/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$140.00+15.14%
1/3/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$133.00 ➝ $137.00+13.70%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$120.00 ➝ $125.00+6.56%
11/13/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Outperform ➝ Market Outperform$160.00 ➝ $140.00+31.14%
10/20/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$120.00+14.56%
8/28/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$139.00+20.62%
8/2/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$157.00+22.29%
8/2/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$116.00 ➝ $125.00-3.84%
5/18/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/18/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/18/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$160.00 ➝ $165.00+22.19%
5/3/202358.com
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/3/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$121.00 ➝ $147.00+4.13%
5/3/2023FIG Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral
5/3/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral
5/3/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$145.00 ➝ $172.00+20.27%
5/3/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$136.00 ➝ $152.00+6.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:55 AM ET.

ZBH Price Target - Frequently Asked Questions

What is Zimmer Biomet's consensus rating and price target?

According to the issued ratings of 15 analysts in the last year, the consensus rating for Zimmer Biomet stock is Hold based on the current 1 sell rating, 9 hold ratings and 5 buy ratings for ZBH. The average twelve-month price prediction for Zimmer Biomet is $139.39 with a high price target of $172.00 and a low price target of $120.00. Learn more on ZBH's analyst rating history.

Do Wall Street analysts like Zimmer Biomet more than its competitors?

Analysts like Zimmer Biomet less than other Medical companies. The consensus rating for Zimmer Biomet is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how ZBH compares to other companies.

Does Zimmer Biomet's stock price have much upside?

According to analysts, Zimmer Biomet's stock has a predicted upside of 12.55% based on their 12-month stock forecasts.

What analysts cover Zimmer Biomet?

Stock Ratings Reports and Tools

This page (NYSE:ZBH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners